Country Profile

Venezuela

Venezuela is a growing market for Indian pharmaceuticals — $90.3M in FY 2025–26. Medicines accounts for 93% of shipments, with vaccines contributing $2.57M.

🇻🇪 $90.3M · 0.6× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$90.3M
Exports FY2025–26 DGCIS
0.6×
Growth FY2015→2026
93%
Medicines Share
5
Product Categories Supplied
12
Years of Trade Data
Venezuela is a growing market for Indian pharmaceuticals — $90.3M in FY 2025–26. Medicines accounts for 93% of shipments, with vaccines contributing $2.57M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $83.6M (92.6%) Medicine Ingredients $2.79M (3.1%) Vaccines $2.57M (2.8%) Surgical & Hospital Supplies $1.24M (1.4%) Traditional & Herbal $61K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Venezuela in the RBI overseas direct investment dataset (2011–2026).